Riskpilot← Back to searchSign inGet full accessIRRAS AB
ABIn liquidationOrg 5568727134Vasagatan 16Research and experimental development on natural sciences and engineering · NACE 7210Est. 20110 employees
Revenue 2024
SEK 1,3M
EBITDA margin
-499.4%
+82% vs 2023
Equity ratio
68.4%
Financial strength
Net profit 2024
SEK -13,6M
+63% vs 2023
| Revenue | SEK 1,3M | — |
| EBITDA | SEK -6,3M | +82% |
| Net profit | SEK -13,6M | +63% |
| Total assets | SEK 621,4M | +11% |
| Equity | SEK 424,9M | -11% |
| Employees | 0 | — |
Legal name
IRRAS AB
Org number
5568727134
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
21 november 2011
Share capital
SEK 33 992 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Föremålet för bolagets verksamhet är att utveckla, marknadsföra och sälja medicinteknisk utrustning, direkt eller indirekt äga och förvalta fast eller lös egendom och därmed förenlig verksamhet.
Address
Vasagatan 16
Phone
+46102115170
Email
mikael.klang@snellman.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 726 | 742 | 414 | 0 | 1 259 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −40 091 | −38 076 | −44 782 | −34 927 | −6 287 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −40 091 | −38 076 | −44 782 | −34 927 | −6 287 |
| Net financials | −1 132 | −220 177 | −31 587 | −1 630 | −7 311 |
| Profit before tax | −41 224 | −258 252 | −59 438 | −36 557 | −13 599 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −41 224 | −258 252 | −59 438 | −36 557 | −13 599 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 517 486 | 319 256 | 466 377 | 558 163 | 621 428 |
| Equity | 509 352 | 313 864 | 454 185 | 479 170 | 424 879 |
| Long-term debt | 0 | 0 | 0 | 0 | 189 909 |
| Short-term debt | 8 134 | 5 391 | 12 192 | 78 993 | 6 640 |
| Total debt | 8 134 | 5 391 | 12 192 | 78 993 | 196 549 |
EBITDA margin
-499.4%
This company
15.8%
Market median
-3261% vs market
20202024
Equity ratio
68.4%
This company
38.2%
Market median
+79% vs market
20202024
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20202024
Net profit margin
-1080.1%
This company
8.1%
Market median
-13435% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HM Liquidator | Liquidator | 2026 |
UC Chief Auditor | Chief Auditor | 2026 |
| Former (6) | ||
TG Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
DB Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2025 |
CW Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
SB Chief Auditor | Chief Auditor | 2020 – 2026 |
KG Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
SM Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (8) | ||
| Board of Directors | 2022 – 2023 | |
| Chairman | 2021 – 2025 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2022 – 2023 | |
| Board of Directors | 2020 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 91% | 91% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
IRRAS HOLDINGS INC
IRRAS AB (this company)Irras GmbhIrras IncIrras BvIRRAS INCBoard members of IRRAS AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tore Gustaf Linghede | Chief Executive Officer | 0 companies |
| Hans Mikael Klang | Liquidator | 0 companies |
| Daniel Björn Sveen | Authorized Recipient of Service | 0 companies |
| Ulf Christer Sundborg | Chief Auditor | 0 companies |
| Carl William Martin Jr | Chief Executive Officer | 0 companies |
| Stefan Bo Lundberg | Chief Auditor | 0 companies |
| Kleanthis Gabriel Xanthopoulos | Chief Executive Officer | 0 companies |
| Sten Mauritz Gustafsson | Chief Executive Officer | 0 companies |
| Anita Gunnel Tollstadius | Board of Directors | 0 companies |
| Nils Anders Olof Clausson | Chairman | 0 companies |
| Anders Paul Wiklund | Chairman | 0 companies |
| Michel Joseph Lucien Pettigrew | Board of Directors | 0 companies |
| Danilo D'Alessandro | Board of Directors | 0 companies |
| Ellisa Cholapranee | Board of Directors | 0 companies |
| Joseph Michael Burnett | Chairman | 0 companies |
| Eva Alva Maria Nilsagård | Board of Directors | 0 companies |
| Marios Fotiadis | Chairman | 0 companies |
| Salameh Sweis | Board of Directors | 0 companies |
| Chaterine Gilmore-Lawless | Board of Directors | 0 companies |